ANALGESICS IN THE UNITED ARAB EMIRATES

Euromonitor International

January 2019

LIST OF CONTENTS AND TABLES

Headlines

Prospects

Demand for Analgesics Driven by Common Ailments

Topical Analgesics Least Impacted by Macroeconomic Influences

Competitive Landscape

GlaxoSmithKline Continues To Lead Analgesics

Dominance for International Brands Prevail As Local Players Benefit From Price- Sensitive Customers

Category Data

Table 1 Sales of Analgesics by Category: Value 2013-2018

Table 2 Sales of Analgesics by Category: % Value Growth 2013-2018

Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2013-2018

Table 4 NBO Company Shares of Analgesics: % Value 2014-2018

Table 5 LBN Brand Shares of Analgesics: % Value 2015-2018

Table 6 Forecast Sales of Analgesics by Category: Value 2018-2023

Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2018-2023

Executive Summary

Consumer Health Records Negligible Recovery in 2018

Government Initiatives Complement Recovery

Introduction of 5% Value Added Tax Increases Preventive Medicine Costs

Chained Chemists/pharmacies Lead Distribution With Deals

Recovery Expected From Launch of New Health Care Institutions

Market Indicators

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018

Table 9 Life Expectancy at Birth 2013-2018

Market Data

Table 10 Sales of Consumer Health by Category: Value 2013-2018

Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018

Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018

Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018

Table 14 Distribution of Consumer Health by Format: % Value 2013-2018

Table 15 Distribution of Consumer Health by Format and Category: % Value 2018

Table 16 Forecast Sales of Consumer Health by Category: Value 2018-2023

Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventative Medicine

Switches

Sources

Summary 1 Research Sources

The first line of medicine for common ailments such as pain, fever, and flu symptoms in the United Arab Emirates continued to be analgesics. Therefore, demand was heavily influenced by habit persistence among residents, whether expat or locals. It was highly common to find analgesics such as Panadol or Brufen in a household throughout the year. In addition, health insurance usually covers analgesics within a scheme and therefore, is free of cost for consumers if recommended by the doctor and pre...

Euromonitor International's Analgesics in United Arab Emirates report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.